April 30, 2021

study looking at immune response to variants after one dose of Pfizer

A new paper, published in Science at 3pm this afternoon, looks at the immune responses in UK healthcare workers following their first dose of the Pfizer/BioNTech vaccine and their level of protection against as the Kent and South Africa variants, depending on whether they had previously had SARS-CoV-2 infection.

The researchers looked an antibodies, T cells and B cells.

Journalists dialled in to this briefing to hear from the authors of the study and to ask them any questions.

Speakers included:

Prof Rosemary Boyton, Professor of Immunology and Respiratory Medicine, Imperial College London

Prof Danny Altmann, Professor of Immunology, Imperial College London